pharma news

News

GSK claims FDA okay for first oral carbapenem antibiotic

GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.

News

AI agents can beat doctors in clinical decision-making

Two AIs have shown they can match doctors across diagnostic and treatment tasks, but their developers say they aren't ready yet for real-world use.

News

RayThera founders Qing Dong and Gene Hung

Biogen pens $1bn deal to buy immunology biotech RayThera

Biogen has agreed its second takeover deal of 2026, an acquisition of immunology start-up RayThera valued at up to $1 billion.

News

uniQure sets course to US filing for Huntington gene therapy

Shares in uniQure have rocketed this morning, as it emerges that the FDA will not require it to run a new trial of Huntington's gene therapy AMT-130.

News

Jazz orchestrates a $4bn cancer alliance with AbCellera

Jazz Pharma has made a big move into T-cell engagers (TCEs) for solid tumours, via an alliance with Canadian biotech AbCellera.

News

MSD steps out with Protillion in $510m+ AI shindig

MSD has teamed up with Protillion Bio in a deal worth more than $510m, focusing on using the AI start-up's lab-in-the-loop platform for drug discovery

GSK claims FDA okay for first oral carbapenem antibiotic

AI agents can beat doctors in clinical decision-making

Biogen pens $1bn deal to buy immunology biotech RayThera

uniQure sets course to US filing for Huntington gene therapy

Jazz orchestrates a $4bn cancer alliance with AbCellera

MSD steps out with Protillion in $510m+ AI shindig

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks